1. Access to Insulin: Current Challenges and Constraints;David Beran;Health Action International,2017
2. This report confirms from different data perspectives the dominance of Eli Lilly, Novo Nordisk, and Sanofi with regards to the global insulin market. Although other insulin manufacturers have been identified based on the data available, their size and market penetration seem to be low;R O Beran;Trade Flows'),2019